Team: Bios

Steven St. Peter, MD, MBA Managing Director

Dr. Steven St. Peter joined MPM in 2004 with experience from Apax Partners and The Carlyle Group, where his investment scope included both venture and buyout transactions across medical technology and pharmaceuticals. He began working at MPM in 2003 and was promoted to General Partner in 2005. Dr. St. Peter was previously an assistant Clinical Professor of Medicine at Columbia University. He completed his Doctor of Medicine at Washington University and his residency and fellowship at the Hospital of the University of Pennsylvania. Prior to his medical training, he was an investment banker at Merrill Lynch. He also holds an M.B.A. from the Wharton School of the University of Pennsylvania and a B.A. in Chemistry from the University of Kansas. He is on the Board of the New England Venture Capital Association.

Present Boards
EKR Therapeutics, Inc.
MPM Acquisition Corp.
PharmAthene, Inc. (ASE:PIP)
Syndax Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. (NASDAQ:XANO)

Past Boards
Atugen AG
Helicos BioSciences Corp. (NASDAQ:HLCS)
IDEA AG
Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI)